Latest

psychopharmacology

Featured Neuroscience Open Neuroscience Articles Psychology

·April 11, 2019·3 min read

Ketamine reverses neural changes underlying depression-related behaviors: Mouse study

The formation of prefrontal cortex dendritic spine formation sustains the remission of depressive related symptoms and behaviors following ketamine treatment by restoring lost spines.

This image shows a lot of brightly colored pills

Featured Neuroscience Open Neuroscience Articles Psychology

·April 8, 2019·5 min read

Anti-inflammatory medicine can have a beneficial effect on depression

Anti-inflammatory medications, such as those commonly prescribed for arthritis, improve depressive symptoms in those with MDD.

This shows a brain overlayed on a person's head with a swirly, psychedelic background

Featured Neuroscience Psychology

·April 4, 2019·5 min read

Psychedelic drug MDMA may reawaken ‘critical period’ in brain to help treat PTSD

MDMA, a psychedelic drug, has successfully been used to reopen the 'critical period' of learning the reward values of social behaviors. Researchers report, in mature mice given MDMA, oxytocin triggers signaling in synapses that help encode social learning and memory, a process that does not usually occur in older animals. The findings could help in the development of treatments for PTSD and other disorders.

This shows a photo of a woman with her face cut out

Featured Neurology Neuroscience Psychology

·April 3, 2019·2 min read

Psychostimulants play a major role in fatal strokes among young adults

Psychostimulant use in young adults is correlated with an increased risk of stroke.

This is the chemical structure of ketamine

Featured Neuroscience Psychology

·March 30, 2019·4 min read

Researchers Discover How a Critical Receptor is Involved in the Response to Fast-Acting Antidepressants Like Ketamine

The mGlu2 receptor plays a critical role in the effectiveness of ketamine for treating depression.

Featured Genetics Neuroscience Psychology

·March 22, 2019·4 min read

When neurons are out of shape, antidepressants may not work

Differences in serotonergic neuron morphology, along with altered gene expression have been identified in patients with MDD. The findings shed light on why some patients do not respond to SSRI antidepressants.

Featured Neuroscience Psychology

·March 18, 2019·3 min read

Fast-acting psychedelic associated with improvements in depression/anxiety

5-MeO-DMT, a fast-acting synthetic psychedelic, shows promise for treating depression and anxiety. 80% of test subjects reported improvements in symptoms associated with depression and anxiety after taking the drug.

Featured Neuroscience Psychology

·February 25, 2019·3 min read

Ritalin Has No Effect on Primate Prefrontal Cortex

Even at doses that help improve monkeys' attention, researchers observe no differences of neural activity in the prefrontal cortex after administering Ritalin.

Featured Psychology

·February 22, 2019·5 min read

Combination Therapy May Be Beneficial For Schizophrenia Treatment

A new study reports combining antipsychotic medications could help to prevent relapse and hospitalization for those with schizophrenia. Combining aripiprazole and clozapine resulted in a 23% lower risk of re-hospitalization than with clozapine alone, researchers report.

Featured Neuroscience Psychology

·February 17, 2019·6 min read

Heartbeats and Memory Suppression: The New Tools for Controlling Fear

From designing drugs to help suppress traumatic memories, to harnessing the power of heartbeats, researchers are searching for new therapies to help people overcome their fears and phobias.

Featured Neuroscience Open Neuroscience Articles Psychology

·February 11, 2019·5 min read

Does Microdosing Improve Mood and Performance?

A new study reports those who microdose psychedelics report improvements in attention and mental health. However, a number of people report an increase in neuroticism following six weeks of microdosing.